ACI - 11th National Forum on Fraud and Abuse in the Sales and Marketing of Drugs Conference

The staggering amount of recovery reflects the growing number and scale of False Claims Act suits against the pharmaceutical industry. Recent statutory amendments are likely to further accelerate growth in the number of FCA cases filed by whistleblowers. A robust compliance program is essential to ferret out potential fraud and abuse problems before they become the subject of costly whistleblower claims and off-label investigations. ACI’s 11th National Forum on Fraud and Abuse in the Sales and Marketing of Drugs is the leading industry event where you will hear directly from the leading government enforcers and in-house compliance executives, who will share their experiences and strategies.

Robert Rhoad is one of the presenters at this conference. The topic is, “Health Care Reform 1 Year Later: Identifying Recent Health Care Reform Trends and the Continuing Effect on the Pharmaceutical Industry."